Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment

N/AUnknownNCT06194760

Al-Azhar University13 enrolled

Overview

Retinal detachment (RD) resulting from the macular hole (MH), also known as MH-induced RD (MHRD), most commonly occurs in eyes with high myopia and results in irreversible visual disorders. Although ILM peeling for MHRD reportedly achieves a high retinal reattachment rate that ranges from 70% to 100%, the MH closure rate is relatively low, ranging from 10% to 70%.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Retinal Detachment

Interventions

Vitrectomy with ILM peelingPROCEDURE

Vitrectomy with traditional internal limiting membrane (ILM) peeling technique is regarded as the gold standard treatment for MH; it works by completely relieving of the traction of the macula and increasing the flexibility of the retina

Eligibility

Sex: ALLMin age: 15 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with high myopia (a spherical equivalent refractive error of at least -6.0 diopters (D) and an axial length of at least 26.5 mm). * Macular hole and only posterior retinal detachment Exclusion Criteria: * Other causes of RD * Patients with a history of trauma, choroidal neovascularization, coexistence with a peripheral retinal break or proliferative vitreoretinopathy * History of any vitreoretinal surgery prior to MHRD and less than 36 months of follow-up after the surgery

Locations (1)

Ehab tharwat

Damietta, New Damietta, Egypt

Outcomes

Primary Outcomes

Closure of macular hole

It is a subjective outcome measured by Optical coherence tomography and by clinical slit lamb examination

Time frame: 6 months post operative

BCVA

It is a measure of the visual acuity, which will be measured by LogMar

Time frame: baseline

BCVA

It is a measure of the visual acuity, which will be measured by LogMar

Time frame: 6 months postoperative

BCVA

It is a measure of the visual acuity, which will be measured by LogMar

Time frame: 12 months postoperative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.